Search clinical trials for: TGRX-326

Total 998 results

University of Iowa

Completed

Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety

Post Partum Depression | Perinatal Depression | Perinatal Anxiety | Post Partum Anxiety

United States
Amgen

Completed

Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma

Gastrointestinal Cancer
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

Dyslipidemia Patients With Hypertension

Korea, Republic of
Kowa Research Institute, Inc.

Completed

A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery

Corneal Edema After Cataract Surgery

United States, Puerto Rico
GE Healthcare
Quintiles, Inc.; Covance; ABX CRO; Examination Management Services Inc.; Averion...

Terminated

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography

Diabetes Mellitus | Renal Insufficiency

United States, United Kingdom
Centocor, Inc.

Completed

A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

Lymphoma, Non-Hodgkin | Multiple Myeloma | Giant Lymph Node Hyperplasia

United States
AstraZeneca

Completed

Study of CP-675,206 in Refractory Melanoma

Refractory Melanoma

United States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
Southwest Oncology Group
National Cancer Institute (NCI)

Withdrawn

S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Kidney Cancer
M.D. Anderson Cancer Center

Withdrawn

Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients

Melanoma | Advanced Cancers
pSiMedica Limited
Singapore General Hospital; Guy's and St Thomas' NHS Foundation Trust; pSiOncology...

Unknown

32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer

Pancreatic Cancer

Singapore, United Kingdom
Synta Pharmaceuticals Corp.

Completed

STA-5326 in Crohn's Disease Patients

Crohn's Disease

United States
Jagiellonian University

Recruiting

Quality of Life in Normogonadotropic Anovulation

Anovulation | Irregular Menses

Poland
Xcovery Holding Company, LLC

Completed

Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer

Advanced Solid Tumors | Non-small Cell Lung Cancer

United States
Yazeed Sawalha

Withdrawn

Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular... and other conditions
AstraZeneca

Recruiting

A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS) (VATHOS)

Asthma

United States, Canada, Italy, Japan, Vietnam, Spain, Germany, Malaysia
Gila Therapeutics, Inc.

Completed

A Dose Escalating Study to Assess the Safety and Tolerability of GT-001

Feeding and Eating Disorders

United States
Exegi Pharma, LLC
The Emmes Company, LLC

Recruiting

Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) (PROF)

Ileal Pouch

United States
BioSight Ltd.

Completed

Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy (ELPIS)

Acute Myeloid Leukemia

United States, Israel
Luye Pharma Group Ltd.

Completed

Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

Prostate Cancer

China
University of Surrey

Completed

Acute Metabolic Effects of Carbohydrate Restriction at Varying Energy Levels

Healthy

United Kingdom
BioSight Ltd.

Recruiting

A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML

AML, Adult

United States
Kowa Research Institute, Inc.

Completed

Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis

Fuchs' Endothelial Corneal Dystrophy

United States, Australia, Germany, Spain, Denmark
Applied Molecular Transport

Completed

SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects

Healthy Volunteers

United Kingdom
Duke University

Completed

Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)

Coronary Computed Tomographic Angiography
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections

Sepsis | Fungemia | Bacteremia

United States
Debiopharm International SA

Recruiting

A Study to Assess the Efficacy, Safety and Pharmacokinetics of Debio 4326 in Pediatric Participants Receiving Gonadotropin-Releasing Hormone Agonist Therapy for Central Precocious Puberty (LIBELULA)

Central Precocious Puberty

United States
AstraZeneca

Completed

A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States, Canada, Germany, Argentina, Bulgaria, Poland, Turkey, Mexico, United Kingdom
Orion Corporation, Orion Pharma

Completed

To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product (BUFODIL)

Asthma

Bulgaria
AstraZeneca

Recruiting

A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS) (LITHOS)

Asthma

United States, Canada, South Africa, Korea, Republic of, Philippines, Czechia, Malaysia, Germany
Centocor, Inc.

Completed

A Study to Assess the Safety and Pharmacokinetics of a Single Intravenous Administration of CNTO 328 Derived From 2 Different Cell Lines in Healthy Participants

Healthy

United States
University Clinic Frankfurt

Completed

Prospective Study of Long-term Outcome After Non-aneurysmal Subarachnoid Hemorrhage

Subarachnoid Hemorrhage
University of Guarulhos

Completed

Selective Enamel Etching in Self-etching Adhesives: a 2-year Clinical Trial

Selective Enamel Etching in Dental Restorations
Kazia Therapeutics Limited

Completed

Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

United States, Australia
Amgen

Completed

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma

Carcinoma | Cancer | Metastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Metastatic Cancer | Colon Cancer | Gastrointestinal Cancer | Oncology | Metastases
Goztepe Training and Research Hospital

Completed

The Effect of SGLT2 Inhibitors on Heart Rate Variability and BDNF Levels in Patients With Type 2 Diabetes

Type 2 Diabetes | Heart Rate Variability

Turkey
Instil Bio

Active, not recruiting

ITIL-306 in Advanced Solid Tumors

Renal Cell Carcinoma | Epithelial Ovarian Cancer | Non-small Cell Lung Cancer

United States
China Medical University Hospital

Completed

Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic Stroke

Stroke | Hemorrhagic Transformation Due to Acute Stroke
Gitte Moos Knudsen

Completed

[11C]Cimbi-36 Dosimetry

Healthy

Denmark
Luye Pharma Group Ltd.

Completed

Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®

Breast Cancer

China
National Institute of Allergy and Infectious Diseases...

Completed

The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease

Crohn's Disease

United States
Baylor College of Medicine
National Institute on Drug Abuse (NIDA)

Withdrawn

RTI-336 as a Treatment for Methamphetamine Dependence

Substance Abuse | Methamphetamine Dependence | Methamphetamine Abuse
National Cancer Institute (NCI)

Completed

Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States
Pearl Therapeutics, Inc.

Completed

Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

COPD

United States
Pfizer

Completed

Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults

Obesity

United States
University Health Network, Toronto

Terminated

Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients

Metastatic Breast Cancer

Canada
Synta Pharmaceuticals Corp.

Completed

Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease

Crohn's Disease

United States, Canada
Virometix
Center of Vaccinology, Ghent, Belgium (CEVAC); Expert Clinical Services Organization...

Completed

Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus

Acute Bronchiolitis Due to Respiratory Syncytial Virus

Belgium
National Institute of Allergy and Infectious Diseases...

Completed

STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency

Common Variable Immunodeficiency

United States
Pearl Therapeutics, Inc.

Completed

Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)

COPD

United States, Austria, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Peru, Russian Federation, Hungary, China, Taiwan, Australia, Japan, Argentina, South Africa, Belgium, Czechia, Serbia, Poland, Mexico, New... and more
Massachusetts General Hospital
TG Therapeutics

Terminated

Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma

Lymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma Grade IIIa | Marginal Zone B Cell Lymphoma | Follicular Lymphoma Grade 2

United States

Search clinical trials for: TGRX-326

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations